GlassScriptPhysician profile
Alan J Franklin
NPI 1366492365
$97,206.46
in general payments reported to CMS, 2019-2025
26 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what 82% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $6,601 · 2021: $17K · 2022: $27K · 2023: $6,283 · 2024: $12K · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,060 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,933.00 |
| Food and Beverage | $4,060.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $52,130.06 | 2019-2025 | Ngenuity |
| Alcon Vision LLC | $39,532.72 | 2019-2025 | Constellation, Ngenuity, Unity |
| Oculus Surgical INC. | $957.54 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $569.62 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $493.35 | 2022-2025 | Vabysmo |
| Novartis Pharmaceuticals Corporation | $483.49 | 2019-2023 | |
| Carl Zeiss Meditec USA, INC. | $411.13 | 2023-2024 | Iolmaster 700, Clarus |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $350.76 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $291.57 | 2022-2023 | Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $288.64 | 2023-2025 | Syfovre |
| Optos, INC. | $234.88 | 2019 | |
| Bausch & Lomb Americas INC. | $223.22 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Kala Pharmaceuticals, INC. | $178.43 | 2019 | |
| Astellas Pharma US INC | $171.55 | 2023-2025 | Izervay |
| Allergan, INC. | $164.69 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $146.01 | 2020-2024 | Iluvien, Yutiq |
| Carl Zeiss Meditec, INC. | $137.05 | 2020 | |
| Eyevance Pharmaceuticals LLC | $105.00 | 2019 | |
| Abbvie INC. | $86.49 | 2022-2023 | |
| Neurotech Pharmaceuticals, INC. | $85.75 | 2025 | |
| Horizon Therapeutics Plc | $41.20 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $39.57 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $27.43 | 2023 | Tyrvaya |
| Alexion Pharmaceuticals, INC. | $19.23 | 2021 | |
| Amgen INC. | $18.97 | 2025 | |
| Aerie Pharmaceuticals, INC. | $18.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.